FIM-4269

N/A

Report date: 2022/08/24 20:00:31
NME

Base Information

Drug NameFIM-4269
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCell adhesion molecules inhibitors
TargetsCell adhesion molecules
Therapy Area/IndicationsUrinary Tract Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesFimbrion Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesFimbrion Therapeutics IncGlaxosmithkline Plc
Active IndicationsN/A
Inactive IndicationsUrinary Tract Infections

Other Information

ATC CodeN/A
Related LinksN/A